BUYOUT INVESTIGATION: Does $28.00 Per Share Buyout Offer Shortchange STAAR Surgical Company (NASDAQ: STAA) Shareholders? Kaskela Law LLC is Investigating the Buyout Offer and Encourages STAA Shareholders to Contact the Firm

Core Viewpoint - Kaskela Law LLC is investigating the fairness of the shareholder buyout offer made to STAAR Surgical Company, particularly focusing on whether the proposed price of $28.00 per share is adequate compared to the company's 52-week high of $38.60 per share, and concerns regarding conflicts of interest in the sales process [1]. Summary by Relevant Sections Shareholder Buyout Offer - STAAR Surgical Company has agreed to be acquired by Alcon at a price of $28.00 per share, which is significantly lower than its 52-week high of $38.60 per share [1]. - The investigation by Kaskela Law LLC aims to determine if the buyout proposal is fair and provides sufficient monetary consideration for STAAR's investors [1]. Conflicts of Interest - Initial findings from the investigation suggest that there are significant conflicts of interest associated with the transaction, raising concerns about the fairness of the sales process and the consideration offered to shareholders [1]. - STAAR's largest shareholder has expressed serious concerns regarding the fairness and integrity of the sales process, indicating that the acquisition may not be in the best interest of STAAR's shareholders [1].